Newsroom
Sorted by: Latest
-
Caidya、COOにマイケル・クレイを任命 オペレーションの卓越性推進と複数地域臨床開発の加速へ
ノースカロライナ州ローリー--(BUSINESS WIRE)--(ビジネスワイヤ) -- Caidyaは、革新的なバイオ医薬品企業の臨床開発加速に注力するグローバルな中堅規模の医薬品開発業務受託機関(CRO)として、マイケル・クレイを最高執行責任者(COO)に任命したことを発表しました。クレイは、Caidyaのグローバルなオペレーショナル・デリバリー、顧客対応モデル、および実行戦略を統括し、米国、欧州、アジア太平洋地域にまたがる革新的バイオ医薬品のスポンサー企業に対する同社のサービス提供能力をさらに強化します。 クレイは、グローバルなプロジェクト遂行と治験実施施設(サイト)との関係構築戦略において、卓越した実績を有しています。60か国以上にわたる大規模なグローバル・プログラムを率い、オペレーションの厳格さとスポンサーからの信頼で知られる高い成果を上げるデリバリー組織を構築してきました。 特にクレイは、スピード、規制上のきめ細かな対応、そしてサイトとの緊密な連携が成功の鍵となるアジア太平洋地域において、豊富なリーダーシップ経験を有しています。サイトとのパートナーシップと地域での実行に対...
-
Falcon’s Beyond Appoints Iraida Que De Vera to Board of Directors
ORLANDO, Fla.--(BUSINESS WIRE)--Falcon’s Beyond Global, Inc. (Nasdaq: FBYD) (“Falcon’s Beyond”, “Falcon’s”, or the “Company”), a visionary leader in innovative and immersive storytelling today announced the appointment of Iraida Que De Vera to the Company’s Board of Directors. Iraida Que De Vera is the Founder and CEO of Amor Maximus, a private family office and strategic advisory platform focused on real estate, capital stewardship, and multigenerational legacy planning. Iraida Que De Vera has...
-
Caidya ernennt Michael Clay zum COO, um die operative Exzellenz zu fördern und die multiregionale klinische Entwicklung voranzutreiben
RALEIGH, North Carolina--(BUSINESS WIRE)--Caidya, ein führendes globales mittelständisches Auftragsforschungsunternehmen (Contract Research Organization, CRO), dessen Schwerpunkt auf der Beschleunigung der klinischen Entwicklung für innovative biopharmazeutische Unternehmen liegt, gab heute die Ernennung von Michael Clay zum Chief Operating Officer (COO) bekannt. Clay wird die globale operative Bereitstellung, das Kundenbindungsmodell und die Umsetzungsstrategie von Caidya verantworten und die...
-
Riassunto: Caidya nomina Michael Clay al ruolo di COO: guiderà l'eccellenza operativa e promuoverà lo sviluppo clinico multiregionale
RALEIGH, Carolina del Nord--(BUSINESS WIRE)--Caidya, importante CRO globale di medie dimensioni focalizzata sull'accelerazione dello sviluppo clinico per conto delle case biofarmaceutiche innovative, oggi annuncia la nomina di Michael Clay a direttore operativo (COO). Clay dirigerà le attività globali di distribuzione operativa, il modello di coinvolgimento dei clienti e la strategia di esecuzione di Caidya, oltre a consolidare ulteriormente le capacità dell'azienda al servizio di innovativi sp...
-
Resumen: Caidya nombra a Michael Clay como director de operaciones para impulsar la excelencia operativa y promover el desarrollo clínico multirregional
RALEIGH, NC--(BUSINESS WIRE)--Caidya, una CRO mediana líder a nivel mundial, centrada en acelerar el desarrollo clínico para compañías biofarmacéuticas innovadoras, anunció hoy el nombramiento de Michael Clay como director de operaciones (COO). Clay liderará la ejecución operativa global de Caidya, el modelo de interacción con el cliente y la estrategia de ejecución, lo que fortalecerá aún más la capacidad de la compañía para atender a patrocinadores biofarmacéuticos innovadores en todo Estados...
-
Investor Notice: Robbins LLP Informs Investors of the PayPal Holdings, Inc. Class Action
SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired PayPal Holdings, Inc. (NASDAQ: PYPL) securities between February 25, 2025 and February 2, 2026. PayPal is an international company that enables digital payments to simplify commerce experiences. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigati...
-
Investor Notice: Robbins LLP Informs Investors of the Enphase Energy, Inc. Class Action
SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Enphase Energy, Inc. (NASDAQ: ENPH) securities between April 22, 2025 and October 28, 2025. Enphase is a global energy technology company focusing on solutions for solar generation, storage, and communication. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP...
-
Ordinary Shareholders’ Meeting of Natuzzi S.p.A.
SANTERAMO IN COLLE, Bari, Italy--(BUSINESS WIRE)--ORDINARY SHAREHOLDERS’ MEETING OF NATUZZI S.P.A....
-
Veritone to Hold Fourth Quarter and Full Year 2025 Results Conference Call on March 12th
IRVINE, Calif.--(BUSINESS WIRE)--Veritone, Inc. (NASDAQ: VERI), a leader in building enterprise AI and data solutions, today announced the details of its fourth quarter and full year 2025 financial results conference call. Veritone will hold a conference call on Thursday, March 12, 2026, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time), to discuss its results for the fourth quarter and full year 2025, provide an update on the business and conduct a question-and-answer session. To participate,...
-
Viant Announces Date of Fourth Quarter and Full Year 2025 Financial Results and Conference Call
IRVINE, Calif.--(BUSINESS WIRE)--Viant Technology Inc. (NASDAQ: DSP) today announced it will release its fourth quarter and full year 2025 financial results after U.S. markets close on Wednesday, March 11, 2026. Viant will host a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss business and financial performance. Fourth Quarter and Full Year 2025 Results and Conference Call Date: Wednesday, March 11, 2026 Time: 2:00 p.m. Pacific Time / 5:00...